Exploration of Orally Disintegrating Tablet for Sublingual Vaccination against Mucosal Bacterial Infection
This study demonstrates that a novel sublingual, orally disintegrating tablet vaccine (Capot) utilizing bacterial extracellular vesicles encapsulated in a calcium phosphate nanoshell effectively induces durable salivary sIgA immunity and provides robust protection against periodontitis in mice and non-human primates without causing inflammation.